Top 300 Pharmacy Drug Cards 22

+ smart search suggestions

Downloads
Revenue

Description

The quickest, most efficient way for mastering critical facts about common drugs
Perfect for NAPLEX and course review, McGraw Hill's 2022-2023 Top 300 Pharmacy Drug Cards is the most concise and up-to-date resource for building a solid knowledge base of the most commonly used drugs.
Each card includes:
• Generic and common name
• Dosage Forms
• Approved Dose and Indications
• Off-Label Use
• Contraindications
• Adverse Reactions
• Drug Interactions
• Monitoring Parameters
• Medication Safety Issues and Black Box Warnings
• Strong focus on patient safety
Adverse reactions are organized by common, less common, and rare but serious to help you organize your thoughts for counseling patients
No internet connection needed to view the full app. It is all ready for super quick image and information retrieval. This app is optimized for whatever size device you are using, either phone or tablet.
Each card also features a photograph as well as important drug information. You can also search the entire text with our lightning fast search tool. The search tool shows you suggested words as you type so it is quick and helps with spelling issues. You can also add notes to each drug card, as well as bookmark drug cards as Know and Don't Know to help with studying. You also have the ability to change the text size for easier reading.
This interactive app is based on the full content of McGraw-Hill’s 2022/2023 Top 300 Pharmacy Drug Cards.
ISBN-13: 978-1260467345
ISBN-10: 1260467341

Editors:
Jill M. Kolesar, PharmD, MS, BCPS, FCCP
University Research Professor, Colleges of Pharmacy and Medicine
Director, Precision Medicine Initiatives
Markey Cancer Center
University of Kentucky
Lexington, Kentucky
Lee C. Vermeulen, BSPharm, MS, FCCP, FFIP
Chief Efficiency Officer
UK HealthCare
Professor of Medicine and Pharmacy
University of Kentucky
Lexington, Kentucky
Disclaimer: This app is intended for the education of healthcare professionals and not as a diagnostic and treatment reference for the general population.
Developed by Usatine Media, LLC
Richard P. Usatine, MD, Co-President, Professor of Family & Community Medicine, Professor of Dermatology and Cutaneous Surgery, University of Texas Health Science Center San Antonio
Peter Erickson, Co-President, Lead Software Developer
Hide Show More...

Screenshots

Top 300 Pharmacy Drug Cards 22 FAQ

  • Is Top 300 Pharmacy Drug Cards 22 free?

    Yes, Top 300 Pharmacy Drug Cards 22 is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is Top 300 Pharmacy Drug Cards 22 legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does Top 300 Pharmacy Drug Cards 22 cost?

    Top 300 Pharmacy Drug Cards 22 is free.

  • What is Top 300 Pharmacy Drug Cards 22 revenue?

    To get estimated revenue of Top 300 Pharmacy Drug Cards 22 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Malaysia yet.
Ratings History

Top 300 Pharmacy Drug Cards 22 Reviews

No Reviews in Malaysia
App doesn't have any reviews in Malaysia yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
Chart
Category
Rank
Top Paid
371

Top 300 Pharmacy Drug Cards 22 Competitors

Name
Pathophysiology Review
Anti-HIV Med
Prepry - Top 350 Drugs
Learn the Top 350 Drugs
Thoracic Imaging Fundamentals
Go from essentials to details!
Self Care AZ
OTC Self Treatment Tool
STATworkUP® DDx Clinical Guide
Medical Differential Diagnosis
Surgical Skills
Learn how to suture
Relief Meditation
Creatinine (AIMapps)
Medical Findings Pharmacology
Master Drugs & Pharmacology

Top 300 Pharmacy Drug Cards 22 Installs

Last 30 days

Top 300 Pharmacy Drug Cards 22 Revenue

Last 30 days

Top 300 Pharmacy Drug Cards 22 Revenue and Downloads

Gain valuable insights into Top 300 Pharmacy Drug Cards 22 performance with our analytics.
Sign up now to access downloads, revenue, and more.